Comments for Compassionate Machines. The Ethics of “Artificial Empathy”
Daniel Vorobiof, MD. | Chief Medical Director, Belong.life Jama Oncology, May 2, 2024, doi:10.1001/jamaoncol.2024.0824. I read with interest the Viewpoint opinion written by Drs Koranteng, Lewis and Abel entitled Compassionate Machines. The Ethics of “Artificial Empathy” (Jama Oncology, May 2, 2024, doi:10.1001/jamaoncol.2024.0824) We at Belong.life recently launched the first conversational AI Cancer mentor (Dave) application […]
The Prevalence of Cannabis-related Arrhythmias in Patients with Cancer: Real-world Data Evidence of Patient-reported Outcomes
A Laish-Farkash, L Vasilenko, Noy Moisa, Daniel Vorobiof. Israel Medical Association Journal, vol 25:4:292-297, 2023. Abstract Background: Cannabis consumption is suspected of causing arrhythmias and potentially sudden death. Objectives: To investigate prevalence and temporal relationships between cannabis use and onset of symptomatic arrhythmias among cancer patients using Belong.life, a digital patient powered network application. Methods: […]
Real-world behavioral practices of cancer patients: misconceptions compromising daily life activities
ESMO Real World Data and Digital Oncology Journal | VOLUME 4, 100041, JUNE 2024. Published: May 13, 2024DOI. Authors: E. Shachar, S. Peleg-Hasson, D. Vorobiof, E. Waller, T. Safra, I. Wolf Highlights Background Health-related quality of life is commonly used as an endpoint in clinical trials. While it evaluates the presence of symptoms, it does not measure […]
Weight Loss Targets Realization by Patients Living With Overweight or Obesity – Real World Data
Published: 12 May 2024. Participants: Dan Oieru, Bozhena Haikin, Noy Moisa, Tel Aviv University – School of Medicine, Maccabi Healthcare Services, Belong.Life inc. Background Belong is a digital platform which provides professionally moderated digital communities for several chronic conditions. This platform connects patients, healthcare professionals and care management solutions. MyWeight (MW) is a new patient […]
Real-world behavioral restrictional practices of cancer patients (pts)
Real world data evidence on cancer patients awareness and knowledge of cancer associated thrombosis (CAT) events
Lessons Learned from the Implementation of a Person-Centred Digital Health Platform in Cancer Care
Published: 29 September 2022 Abstract The SARS-CoV-2 (COVID-19) pandemic has accelerated the development and use of digital health platforms to support individuals with health-related challenges. This is even more frequent in the field of cancer care as the global burden of the disease continues to increase every year. However, optimal implementation of these platforms into […]
Financial Toxicity In Cancer Patients Receiving Immunotherapy Drugs
Researched by Belong.Life and published by ESMO, 2020 Authors: D Vorobiof, L Hasid, A Litvin, I Deutsch, E Malki. FT has been described as the harmful personal financial burden faced by all patients receiving cancer treatments. Physicians should not be waiting for behavioural changes such as poor compliance, or low or nonadherence, caused by financial […]
Financial Toxicity in American Patients Receiving Cancer Immunotherapy Drugs
Researched by Belong.Life and published by ASCO, 2020Authors: Daniel A. Vorobiof, Lior Hasid, Alon Litvin, Irad Deutsch, Eliran Malki Background: Real-word data obtained through cutting edge technology paired with consumer mobile devices on 310 worldwide pts, members of Belong.life, an international mobile application, who received immunotherapy for diverse solid tumors, was obtained following a short, […]
Covid 19 infection leading to a subsequent new primary cancer diagnosis, Real-world data (RWD) analysis on members of Belong.life, a global cancer application
Researched by Belong.Life and published by ASCO Authors: Daniel A. Vorobiof, Bozhena Haikin, Alon Litvin, Irad Deutsch, Eliran Malki. Background:Some known viral infections can lead to a diagnosis of cancer (e.g: HPV, HIV, EBV, etc.) Anecdotical reports of a Covid 19 infection, and the subsequent diagnosis of a new cancer have been mentioned by few […]
